Cargando…

Peptide Arrays

Despite the concern over the potential loss of structural information as a result of the use of peptides as opposed to proteins as molecular probes, peptide arrays have been implemented in a broad range of applications including antibody screening and epitope mapping, characterization of molecular i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong, Pelech, Steven, Ruijtenbeek, Rob, Felgenhauer, Thomas, Bischoff, Ralf, Breitling, Frank, Stadler, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193736/
http://dx.doi.org/10.1007/978-3-642-28203-4_7
_version_ 1783528244998307840
author Zhang, Hong
Pelech, Steven
Ruijtenbeek, Rob
Felgenhauer, Thomas
Bischoff, Ralf
Breitling, Frank
Stadler, Volker
author_facet Zhang, Hong
Pelech, Steven
Ruijtenbeek, Rob
Felgenhauer, Thomas
Bischoff, Ralf
Breitling, Frank
Stadler, Volker
author_sort Zhang, Hong
collection PubMed
description Despite the concern over the potential loss of structural information as a result of the use of peptides as opposed to proteins as molecular probes, peptide arrays have been implemented in a broad range of applications including antibody screening and epitope mapping, characterization of molecular interactions, and enzymatic activity profiling, and they have become a valuable tool for proteomics research. In this chapter, we first (Sect. 7.1) recapitulate the development of these arrays and highlight a couple of key improvements in the array production and the application in proteomics research. For clinical and biomarker development applications, it is important to measure entities that are directly related to physiological function (and dysfunction). In this respect, the assessment of enzymatic activities is obviously preferable to genotyping, expression profiling, or even measurement of protein amounts. In Sect. 7.2, an original technology based on peptides arrayed onto a porous support allows detailed profiling of kinase activities in a biological sample. The applications described range from kinase characterization to inhibition profiles, detection of off-target effects, and drug response prediction in a clinical setting, allowing rational choice of the drug to be used. Such directly functional approaches will have an important role in the transition to more personalized medicine. Finally, in Sect. 7.3, a recently developed method for “laser printing” of peptide arrays that will make these approaches much more practical is presented.
format Online
Article
Text
id pubmed-7193736
institution National Center for Biotechnology Information
language English
publishDate 2012
record_format MEDLINE/PubMed
spelling pubmed-71937362020-05-04 Peptide Arrays Zhang, Hong Pelech, Steven Ruijtenbeek, Rob Felgenhauer, Thomas Bischoff, Ralf Breitling, Frank Stadler, Volker Microarrays in Diagnostics and Biomarker Development Article Despite the concern over the potential loss of structural information as a result of the use of peptides as opposed to proteins as molecular probes, peptide arrays have been implemented in a broad range of applications including antibody screening and epitope mapping, characterization of molecular interactions, and enzymatic activity profiling, and they have become a valuable tool for proteomics research. In this chapter, we first (Sect. 7.1) recapitulate the development of these arrays and highlight a couple of key improvements in the array production and the application in proteomics research. For clinical and biomarker development applications, it is important to measure entities that are directly related to physiological function (and dysfunction). In this respect, the assessment of enzymatic activities is obviously preferable to genotyping, expression profiling, or even measurement of protein amounts. In Sect. 7.2, an original technology based on peptides arrayed onto a porous support allows detailed profiling of kinase activities in a biological sample. The applications described range from kinase characterization to inhibition profiles, detection of off-target effects, and drug response prediction in a clinical setting, allowing rational choice of the drug to be used. Such directly functional approaches will have an important role in the transition to more personalized medicine. Finally, in Sect. 7.3, a recently developed method for “laser printing” of peptide arrays that will make these approaches much more practical is presented. 2012-01-17 /pmc/articles/PMC7193736/ http://dx.doi.org/10.1007/978-3-642-28203-4_7 Text en © Springer-Verlag Berlin Heidelberg 2012 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Zhang, Hong
Pelech, Steven
Ruijtenbeek, Rob
Felgenhauer, Thomas
Bischoff, Ralf
Breitling, Frank
Stadler, Volker
Peptide Arrays
title Peptide Arrays
title_full Peptide Arrays
title_fullStr Peptide Arrays
title_full_unstemmed Peptide Arrays
title_short Peptide Arrays
title_sort peptide arrays
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193736/
http://dx.doi.org/10.1007/978-3-642-28203-4_7
work_keys_str_mv AT zhanghong peptidearrays
AT pelechsteven peptidearrays
AT ruijtenbeekrob peptidearrays
AT felgenhauerthomas peptidearrays
AT bischoffralf peptidearrays
AT breitlingfrank peptidearrays
AT stadlervolker peptidearrays